- Home
- EONR vs AZTR Comparison
EONR vs AZTR Comparison
Compare EONR & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EONR
- AZTR
- Stock Information
- Founded
- EONR 2020
- AZTR 2014
- Country
- EONR United States
- AZTR United States
- Employees
- EONR N/A
- AZTR N/A
- Industry
- EONR
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- EONR
- AZTR Health Care
- Exchange
- EONR NYSE
- AZTR Nasdaq
- Market Cap
- EONR 6.0M
- AZTR 5.2M
- IPO Year
- EONR N/A
- AZTR 2023
- Fundamental
- Price
- EONR $0.50
- AZTR $0.31
- Analyst Decision
- EONR Strong Buy
- AZTR
- Analyst Count
- EONR 1
- AZTR 0
- Target Price
- EONR $4.50
- AZTR N/A
- AVG Volume (30 Days)
- EONR 352.0K
- AZTR 471.2K
- Earning Date
- EONR 04-15-2025
- AZTR 05-08-2025
- Dividend Yield
- EONR N/A
- AZTR N/A
- EPS Growth
- EONR N/A
- AZTR N/A
- EPS
- EONR N/A
- AZTR N/A
- Revenue
- EONR $20,269,293.00
- AZTR $7,500.00
- Revenue This Year
- EONR $95.25
- AZTR N/A
- Revenue Next Year
- EONR $68.81
- AZTR N/A
- P/E Ratio
- EONR N/A
- AZTR N/A
- Revenue Growth
- EONR N/A
- AZTR N/A
- 52 Week Low
- EONR $0.35
- AZTR $0.23
- 52 Week High
- EONR $3.15
- AZTR $12.00
- Technical
- Relative Strength Index (RSI)
- EONR N/A
- AZTR 50.54
- Support Level
- EONR N/A
- AZTR $0.27
- Resistance Level
- EONR N/A
- AZTR $0.35
- Average True Range (ATR)
- EONR 0.00
- AZTR 0.03
- MACD
- EONR 0.00
- AZTR 0.00
- Stochastic Oscillator
- EONR 0.00
- AZTR 60.00
About EONR EON RESOURCES INC
EON Resources Inc is an independent upstream energy company focused on maximizing total returns to its shareholders through the development of onshore oil and natural gas properties in the United States. Its current focus is as an upstream energy company producing oil and gas properties in the Permian Basin.
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.